heart team, hybird OR, structural heart team

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve patient outcomes, the heart team approach to cardiac care has gained momentum. This is especially true in the area of structural heart intervention, where the concept was pioneered during the CoreValve and Sapien transcatheter aortic valve replacement (TAVR) trials.

Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic resonance (MR)-conditional heart monitor or pacing or implantable cardioverter defibrillator (ICD) system for their patients.

The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow Inc., the HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, enabling clinicians to select an appropriate treatment.

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent years in favor of novel, more sexy technologies in areas of structural heart repair, transcatheter valves, and new interventional therapies for hypertension, heart failure and stroke.

Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application to participate in the Expedited Access Pathway (EAP) program for its MobiusHD device for the treatment of resistant hypertension.

February 13, 2017 — Vital Images Inc. announced that it will be demonstrating new image sharing capabilities for current Vital customers at the 2017 annual meeting of the Healthcare Information and Management Systems Society (HIMSS), Feb. 19-23 in Orlando, Fla. The solution allows users to share images from different types of media between providers, hospitals and patients.

February 10, 2017 — With the Healthcare Information and Management Systems Society’s annual meeting (HIMSS17) scheduled for Feb. 19-23 in Orlando, Fla., Logicalis Healthcare Solutions outlined five of the top cybersecurity issues currently faced by healthcare chief information officers (CIOs).  

Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt. Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.
The CVRx neo, Baroreflex Neo therapy is for heart failure. It is a pacemaker like device for heart failure therapy. It was cleared by the FDA in August 2019.

In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is partly in response to the Centers for Medicare and Medicaid Services (CMS) targeting HF to reduce the staggering costs of treating patients in an HF crisis, rather than less expensive outpatient treatments.

Rep. Tom Price was confirmed by the U.S. Senate as the new secretary of the Department of Health and Human Services (HHS) by a 52-47 vote early Friday morning.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now